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Abstract 13 
 14 
Insulin (INS) was incorporated into complexes with the block polyelectrolyte 15 
quaternized poly[3,5-bis(dimethylaminomethylene)hydroxystyrene]-b-poly(ethylene 16 
oxide) (QNPHOSEO), which is a cationic-neutral block polyelectrolyte. Light 17 
scattering techniques are used in order to examine the size, the size distribution and 18 
the ζ-potential of the nanocarriers in aqueous and biological media, which are found 19 
to depend on the ratio of the components and the physicochemical parameters during 20 
and after complex preparation. Circular dichroism and infrared spectroscopy, 21 
employed to investigate the structure of the complexed INS, show no alteration of 22 
protein structure after complexation. In vitro release profiles of the entrapped protein 23 
are found to depend on the ratio of the components and the solution conditions used 24 
during preparation of the complexes.  25 
 26 
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1. Introduction 30 
The discovery of insulin revolutionized the use of peptides and proteins as therapeutic 31 
agents for several diseases. The evolution of the biotechnological era gave rise to 32 
modified insulins to solve some of the bottlenecks in insulin therapy (Pillai, and 33 
Panchagnula, 2001; Tibaldi, 2012). Several innovative approaches based on 34 
pharmaceutical nanotechnology mimic the endogenous release and kinetics of insulin, 35 
and also many improved analogues designed achieve better control and effective 36 
treatment of diabetes (Mao et al., 2006; Avadi et al., 2011; Han et al., 2012; Yan et 37 
al., 2012).  38 
 39 
Asymmetric amphiphilic block copolymers self-assemble in aqueous media, to form 40 
core-shell micellar structures and morphologies, with a mesoscopic or nanoscopic 41 
narrow size range and are used for biomedical and pharmaceutical applications (in the 42 
order of 10-100 nanometers). Polyelectrolyte block copolymers constitute an 43 
intriguing class of bio-inspired macromolecules, as they combine the structural 44 
properties of amphiphilic block copolymers, polyelectrolytes and surfactants and 45 
provide various possibilities for use as delivery nanosystems of genes and proteins 46 
through electrostatic complexation (Al-Tahami and Singh, 2007; Hartig et al., 2007; 47 
Pispas, 2007; Reis et al., 2008; Karayianni et al., 2011; Karayianni and Pispas, 2012; 48 
Becker et al., 2012; Haladjova et al., 2012; Varkouhi et al., 2012). Polymeric delivery 49 
systems based on nanoparticles have emerged as a promising approach for insulin 50 
delivery. According to the recent literature, the application of polyion complex 51 
micelles into therapeutic fields is rapidly increasing due to simple and efficient 52 
encapsulation of biopharmaceuticals (peptides and proteins) and outstanding 53 
biocompatibility among various polymer-based drug delivery nanocarriers (Lee and 54 
Kataoka, 2009).  55 
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In the present work we employ dynamic (DLS), static (SLS) and electrophoretic 56 
(ELS) light scattering in order to examine the complexation process, as well as the 57 
structure and solution behavior in aqueous and biological media of the nanosized 58 
complexes, formed between quaternized poly[3,5-59 
bis(dimethylaminomethylene)hydroxystyrene]-b-poly(ethylene oxide) (QNPHOSEO), 60 
a cationic-neutral block copolymer, and insulin (INS). Furthermore, the secondary 61 
structure of the complexed INS was investigated by means of circular dichroism (CD) 62 
and infrared (IR) spectroscopy. Finally, the in vitro release of INS from the 63 
complexes was studied in physiological conditions. The central goal is to create novel 64 
and functional hybrid synthetic/biological macromolecular nanostructures and enrich 65 
the basic understanding on behavior motifs in aqueous and biological media, as well 66 
as widen application potential of nanostructured polymeric delivery systems with 67 
controlled release profile of the encapsulated protein. 68 
2. Materials and Methods 69 
 70 
2.1 Materials 71 
 72 
The synthesis, the physicochemical characterization, as well as the properties of 73 
QNPHOSEO are presented extensively in the recent literature (Mountrichas et al., 74 
2006,2007; Mantzaridis et al., 2009; Stepanek et al., 2011). The QNPHOSEO 75 
polyelectrolyte block copolymer was characterized by SEC, 1H-NMR and FTIR and it 76 
was found to have the following molecular characteristics: Mw=98,600, Mw/Mn=1.09, 77 
15%wt PEO. The molecular structure of QNPHOSEO is presented in Fig. 1(a). 78 
QNPHOSEO chains tend to form loose aggregates in aqueous solutions (Fig. S2) 79 
(Stepanek et al., 2011). The QNPHOSEO block polyelectrolyte has been used for 80 
DNA and RNA complexation and it was found to have cytotoxicity better than other 81 
reference cationic polymers utilized in gene delivery (Varkouli et al., 2012). INS with 82 
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a molecular weight of 5800 g/mol was purchased from Sigma Aldrich and used 83 
without any further purification. 84 
2.1.1 Preparation of QNPHOSEO:INS complexes in different aqueous media  85 
A pH 7 buffer solution was prepared from NaOH and 5mM sodium phosphate. 86 
Moreover, 10mM NaCl were added to solution to maintain a fixed ionic strength, 87 
along with NaN3 in a final concentration of 200ppm, in order to avoid bacterial 88 
growth. Stock solutions of INS and QNPHOSEO were prepared by dissolving a 89 
weighed amount of the dialyzed sample in the appropriate volume of the buffer and 90 
the solutions were left to stand overnight for better equilibration. 91 
The complexes were prepared by adding different amounts of the INS solutions to 92 
QNPHOSEO solutions of the same volume and concentration, under stirring. Finally, 93 
appropriate volumes of buffer solutions were added to achieve a constant final volume 94 
and ionic strength (equal to that of the buffer solutions) for all solutions prepared. 95 
Thus, the concentration of QNPHOSEO was kept constant throughout the series of 96 
solutions, while that of INS varied in order to control the required ratio of the two 97 
components (or equivalently the [-]/[+] charge ratio of the mixture). The solutions of 98 
the complexes developed a bluish tint or turbidity upon mixing, indicating the 99 
formation of supramolecular complexes. Subsequently, the solutions of the complexes 100 
were left for equilibration overnight, which in some cases resulted in coacervation, i.e. 101 
liquid-liquid phase separation of the solution, depending on the INS concentration and 102 
pH. Stable solutions were further characterized as discussed below. 103 
For the ionic strength dependent light scattering measurements, the ionic strength of 104 
the solution was gradually increased by the addition of appropriate aliquots of 1N 105 
NaCl solution at pH=7.00 or 7.40, to 1ml of the previously prepared solutions of the 106 
complexes. After each addition the solution was rigorously stirred and left to 107 
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equilibrate for 15min before measurement. Changes in solute concentrations due to 108 
NaCl solution addition were taken into consideration in the analysis of the light 109 
scattering data.    110 
 111 
2.2.2. Insulin association efficiency and in vitro INS release studies 112 
The loading and the release of insulin from complexes was investigated by dialysis 113 
method. The percentage of INS incorporated into complexes was estimated by 114 
spectrophotometry.  INS concentration was estimated with the aid of the following 115 
INS calibration curve in PBS (pH=7.4): 116 
INS concentration (
mg
ml⁄ ) =
absorbance − 0.0213
0.2822
  (R2 = 0.9966) (𝟏) 117 
The absorbance was measured at 277nm. Encapsulation efficiency (EE) was 118 
calculated by using the following equation: 119 
%𝐸𝐸 =
𝑡𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝐼𝑁𝑆 − 𝑓𝑟𝑒𝑒 𝐼𝑁𝑆
𝑡𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝐼𝑁𝑆 (𝑖𝑛𝑖𝑡𝑖𝑎𝑙)
× 100 (𝟐) 120 
All samples were measured in triplicate and are reported as the mean value. 121 
The release profile of INS from the nanovectors was studied in PBS. Nanovectors 122 
incorporating INS (1ml of each sample) were placed in dialysis sacks (molecular 123 
weight cut off 12,000; Sigma-Aldrich). Dialysis sacks were inserted in 10 mL PBS in 124 
shaking water bath set at 37 oC. Aliquots of samples were taken from the external 125 
solution at specific time intervals and that volume was replaced with fresh release 126 
medium in order to maintain sink conditions. The amount of INS released at various 127 
times, up to 10 h, was determined using spectrophotometry at  λmax = 277 nm with the 128 
aid of the calibration curve of the equation (1). All the experiments were carried out in 129 
triplicate, and the data presented are the average of the three measurements. 130 
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2.2. Methods 131 
2.2.1. Dynamic and static light scattering 132 
The hydrodynamic radius (Rh) of nanocarriers and the polydispersity Index (PD.I.) 133 
were measured by dynamic light scattering (DLS) and the ratio of radius of gyration 134 
to hydrodynamic radius (Rg/Rh) was determined by static light scattering (SLS). Mean 135 
values and standard deviations were calculated from three independent samples. For 136 
dynamic and static light scattering measurements, an AVL/CGS-3 Compact 137 
Goniometer System (ALV GmbH, Germany) was used, equipped with a cylindrical 138 
JDS Uniphase 22mV He-Ne laser, operating at 632.8 nm, and an Avalanche 139 
photodiode detector. The system was interfaced with an ALV/LSE-5003 electronics 140 
unit, for stepper motor drive and limit switch control, and an ALV-5000/EPP multi-141 
tau digital correlator.  Autocorrelation functions were analyzed by the cumulants 142 
method and the CONTIN software. Apparent hydrodynamic radii, Rh, at finite 143 
concentrations, were calculated by aid of the Stokes - Einstein equation: 144 
𝑅ℎ =  
𝑘𝐵𝑇
6𝜋𝑛0𝐷
  (𝟑) 145 
where kB is the Boltzmann constant, η0 is the viscosity of water at temperature T, and 146 
D is the diffusion coefficient at a fixed concentration. The polydispersity of the 147 
particle sizes was given as the 
𝜇2
𝛤2⁄
 (PD.I.) from the cumulants method, where Γ is 148 
the average relaxation rate, and μ2 is its second moment. 149 
Light scattering has been used widely in the study of the fractal dimensions of 150 
aggregates. In static light scattering, a beam of light is directed into a sample and the 151 
scattered intensity is measured as a function of the magnitude of the scattering vector 152 
q, with:  153 
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𝑞 =
4𝜋𝑛0
𝜆0
sin(
𝜃
2
)  (𝟒) 154 
where n0 is the refractive Index of the dispersion medium, θ is the scattering angle and 155 
λ0 is the wavelength of the incident light. Measurements were made at the angular 156 
range of 30º to 150º (i.e. the range of the wave vector was 0.0067<q<0.025 nm-1).  157 
The general relation for the angular dependence of the scattered intensity, I(q) is: 158 
𝐼(𝑞)~𝑞−𝑑𝑓  (𝟓) 159 
where df is the fractal dimension of the aggregates with 1≤df ≤3 (df=3 corresponds to 160 
the limit of a completely compact Euclidean sphere where less compact structures are 161 
characterized by lower df values). The above equation is the classical result used to 162 
determine the mass fractal dimension from the negative slope of the linear region of a 163 
log-log plot of I vs. q.  164 
2.2.2. Electrophoretic mobility – microelectrophoresis 165 
The zeta potential (ζ-potential) plays an important role in colloidal stability of 166 
nanoparticles and can be readily measured by the technique of microelectrophoresis. 167 
The zeta potential of chimeric nanostructures was measured using Zetasizer 168 
3000HAS, Malvern Instruments, Malvern, UK. 50μl of the dispersions was 30-fold 169 
diluted in dispersion medium and ζ-potential was measured at room temperature at 170 
633nm. The zeta potentials were calculated from electrophoretic mobilities, μΕ, by 171 
using the Henry correction of the Smoluchowski equation: 172 
𝜁 =
3𝜇𝛦𝑛
2𝜀0 𝜀𝑟
1
𝑓(𝜅𝑎)
  (𝟔) 173 
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where 𝜀0 is the permittivity of the vacuum, 𝜀𝑟 is the relative permittivity, α is the 174 
particle radius, κ is the Debye length, and n is the viscosity of water. The function 175 
f(κα) depends on particle shape. While if κα > 1: 176 
𝑓(𝜅𝛼) = 1.5 +
9
2(𝜅𝛼)
+
75
2(𝜅𝛼)2
  (𝟕) 177 
The above function refers to dispersions of the present study.  178 
2.2.3. Circular dichroism 179 
CD measurements were conducted using a JASCO-715 (Jasco Corp., Tokyo, Japan) 180 
spectropolarimeter with a Peltier-type cell holder, which allows for temperature 181 
control. Wavelength scans in the far UV region (190 to 260 nm) were performed in 182 
Quartz SUPRASIL (HELLMA, GmbH & Co., Müllheim, Germany) precision cells of 183 
0.1 cm path length. Each spectrum was obtained by averaging three successive 184 
accumulations with a wavelength step of 0.5 nm at a 100 nm/min rate, response time 185 
4 s, and bandwidth 5 nm. The absorption spectra were recorded selecting the UV 186 
(single) mode of the instrument. An estimation of the secondary structure elements 187 
was obtained by analyzing the CD spectra using the CDNN algorithm. 188 
2.2.4. Infrared spectroscopy 189 
Infrared spectra of the protein, polyelectrolyte block copolymer and complexes in thin 190 
film form were acquired at room temperature in the range 5000-550cm-1, using a 191 
Fourier transform instrument (Bruker Equinox 55), equipped with a single bounce 192 
attenuated total reflectance (ATR) diamond accessory from SENS-IR. A small aliquot 193 
of each solution was placed on the ATR element and dried under N2 flow before 194 
measurement. For each sample the final spectrum is the average of the three 100-scan 195 
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measurements at 2cm-1 resolution. The measurement of each sample was bracketed by 196 
two background spectra in order to allow the elimination of H2O vapor bands by 197 
interpolation. 198 
3. Results and Discussion 199 
3.1. Physicochemical characterization of QNPHOSEO:INS complexes in aqueous and 200 
biological media 201 
The complexation process between the QNPHOSEO polyelectrolyte and INS at pH=7 202 
and I=0.01M, and in PBS (pH=7.40 and I=0.154M) was first investigated by means of 203 
dynamic light scattering. It should be noted that PBS (pH=7.40) was chosen as 204 
dispersion medium because the pH and the ionic strength of PBS resembles the 205 
conditions met within the human body. At pH=7the electrostatic interactions of the 206 
system are expected to be strong, since the QNPHOSEO polyelectrolyte block carries 207 
two positively charged groups per functionalized monomeric unit and INS has a net 208 
negative charge of -4. The obtained results from DLS measurements at 90° regarding 209 
the values of the hydrodynamic radius, Rh, and the light scattering intensity, I90, 210 
(corrected for the concentration increase) are shown in Figs. 2(a) and (b), as function 211 
of the protein concentration, CINS, in the solutions of the complexes. The structure and 212 
the formation process of QNPHOSEO:INS complexes is represented in Fig. 1(a).  213 
The concentration of QNPHOSEO copolymer is kept constant throughout the series 214 
of aqueous solutions of different ionic strength investigated. It should be pointed out 215 
that at high INS concentration; coacervation of the solutions of the complexes took 216 
place, only at pH=7 and I=0.01M NaCl. This phenomenology was not observed for 217 
the solutions in PBS. DLS results at low ionic strength (I=0.01M) show that all 218 
solutions exhibit a main peak at high Rh values (~80nm), which apparently 219 
corresponds to the formed mixed aggregates (QNPHOSEO:INS complexes) and a 220 
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significantly smaller one at lower Rh values, which most probably denotes the 221 
presence of a small number of free unimer diblock copolymer chains in solution. The 222 
values of the scattering intensity, I90, which is proportional to the mass of the species 223 
in solution, increased gradually as a function of CINS, providing proof of the occurring 224 
complexation (Fig.2(b)), i.e. the mass of the complexes increases as CINS increases. 225 
As protein concentration increases each polyelectrolyte chain interacts with an 226 
increasing number of protein molecules, the degree of charge neutralization becomes 227 
higher and the size distribution of the complexes decreases, especially at the highest 228 
ionic strength (Becker et al., 2012). In contrast I90 (or the mass of the complexes) 229 
shows a more steep increase in the case of PBS solutions, although the protein 230 
concentration range studied in these systems is wider due to the absence of 231 
coacervation. In pH=7, we observed aggregation of the complexes and precipitation 232 
of the supramolecular aggregates, when the initial concentration of insulin was higher 233 
that 0.07mg/ml.  ζ-potential decreases in absolute value as the concentration of the 234 
protein increases in PBS, or equivalently the effective positive charge of the 235 
complexes reduces as a function of the protein concentration (Fig. 3(a)). On the other 236 
hand, ζ-potential values remained unaffected in the lowest ionic strength solutions. It 237 
seems that the ionic strength of the solution plays a significant role in the interactions 238 
and the structure of the resulting complexes. Due to the primary aggregation of 239 
QNPHOSEO chains in aqueous media we expect interactions between QNPHOSEO 240 
aggregates with INS molecules and this initial state of the block polyelectrolyte may 241 
have a significant effect on the structure of resulting QNPHOAEO:INS complexes 242 
under different solution conditions. We also investigated the morphology of the 243 
complexes via their fractal dimension (df), determined by static light scattering. 244 
Although the nanosystems developed in this study are polydisperse in size we can still 245 
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make use of this parameter to extract information on morphological changes, since 246 
size polydispersity is expected to influence the df results of the nanosystems in more 247 
or less a similar way (after all the PDI index values determined by cumulant analysis 248 
lie in the range 0.2-0.3). df was found near to 1.6 for QNPHOSEO:INS aggregates in 249 
PBS (Fig. S4). An increase of df values was observed for QNPHOSEO:INS 250 
complexes in buffer at pH=7.00 as the concentration of the protein increases (Fig. 251 
S4), although the concentration range studied in these systems is narrow due to 252 
coacervation. This observation may be associated by a small change in the 253 
density/morphology of the complexes as INS concentration increases in this case. 254 
The values of Rg/Rh were also calculated (Fig 3.(b)) from multiangle light scattering 255 
measurements. This ratio is sensitive to the shape of particles in solution and can be 256 
used as a rough estimate of the internal morphology of the particles formed after 257 
complexation. This is based on the notion that Rg is a measure of the mass density 258 
distribution around the center of the structure, while Rh defines the outer dimensions 259 
of the particle. According to Burchard (1983), the Rg/Rh ratio takes the values of 0.775 260 
for a hard uniform sphere and 1.0 for vesicles with thin walls, while values of 1.3 to 261 
1.5 indicate a random coil (loose) conformation in the case of macromolecular chains. 262 
In the present case, the Rg/Rh values are near 1.00 for QNPHOSEO:INS in PBS at low 263 
INS concentration .These results may indicate a more well-defined hollow sphere 264 
(vesicle like) structure for the complexes (Fig 3.(b)) or a rather low density full 265 
spherical structure. It should be pointed out that the morphology of mixed aggregates 266 
changes significantly as the concentration of the INS increases (as indicated from 267 
Rg/Rh values) (Fig. 3(b)). At highest concentration of INS (CINS>1x10
-4 g/mL), open 268 
(low density) spherical structures are observed for QNPHOSEO:INS complexes (Fig. 269 
2(e)). On the other hand, the Rg/Rh values indicate open (low density) spherical 270 
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structures for aggregates in the pH=7 buffer of low ionic strength (Fig 3.(b)). These 271 
differences may be a result of the differences in the salinity of the media, especially at 272 
the lower concentration of INS. 273 
According to the literature, it is important to characterize the physicochemical 274 
properties of the complexes formed under different conditions in biological media, 275 
like fetal bovine serum (FBS), because interaction with the proteins of the medium is 276 
expected to alter the physicochemical properties of the nanostructures, thereby 277 
affecting their stability and clearance properties (Arnida Jánat-Ambury et al., 2011). 278 
We investigated the physicochemical characteristics of QNPHOSEO:INS complexes 279 
in Fetal Bovine Serum (FBS). The prepared complexes in aqueous media were diluted 280 
in FBS:PBS 10% v/v (Arnida Jánat-Ambury et al., 2011; Pippa et al., 2012a,b, 281 
2013a,b).. The size of the complexes in biological medium (FBS) was increased from 282 
ca. 50 nm to ca. 200 nm, as a function of INS concentration, compared to the initial 283 
solutions after complex formation (Figs. 4(a) and 5(a)).  In all cases, the 284 
supramolecular aggregates of insulin carrier complexes and plasma proteins remained 285 
smaller than 300nm (within the nanoparticle scale which is important for 286 
nanomedicinal purposes). The values of the scattering intensity, I90, which is 287 
proportional to the mass of the species in solution, did increase in FBS, providing 288 
proof of some additional, but of relatively low extent,  complexation of the block 289 
copolymer/INS nanoparticles with components of FBS, especially in PBS. This 290 
observation indicates that QNPHOSEO copolymer imparts stealth properties and 291 
stability in the complexes, due to the presence of PEO chains that shield the 292 
complexes (it should be noted that no precipitation of the complexes was observed 293 
when in contact with FBS solutions). A shift of ζ-potential of the complexes to 294 
negative values is observed, presumably due to some binding of FBS proteins, which 295 
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can alter the nanoparticle’s effective size and surface properties (the main protein 296 
component of FBS is albumin which carries a negative charge at physiological 297 
conditions) (Fig.4(b) and 5(b) (Arnida Jánat-Ambury et al., 2011; Pippa et al., 298 
2012a,b, 2013a,b). The shift of the ζ-potential to negative values explains the absence 299 
of precipitation of the complexes, because of additional electrostatic stabilization of 300 
the aggregates.  In our opinion, these differences are not statically significant and, 301 
although there is some protein adsorption on the complexes, their size and surface 302 
properties still remain within the limits allowing the use of the present nanosystems as 303 
nanocarriers of insulin. 304 
3.2. Effect of ionic strength 305 
The increase of the ionic strength in the solutions of the complexes induces charge 306 
screening and weakening of the electrostatic interactions, so it is expected to greatly 307 
influence the solution behavior and structure/morphology of the preformed 308 
complexes. In order to investigate this effect, DLS/SLS measurements as a function of 309 
the added NaCl concentration were conducted, and the resulting Rh and I90 (corrected 310 
for the difference in concentration) values for representative solutions of 311 
QNPHOSEO:INS complexes formed at low and high CINS values at pH 7and 7.40 are 312 
shown in Figs. S5 and 6. In the case of complexes prepared at low ionic strength 313 
buffer Rh does not change significantly with an increase of the ionic strength (Fig. 314 
S5(a)). There is a rather small gradual increase of their size. We recall that at low CINS 315 
values the number of interacting protein molecules per polyelectrolyte chain is rather 316 
small, while at high CINS values the formed complexes are characterized by rather 317 
large number of interacting protein molecules per polyelectrolyte chain (Fig. 5(a)) 318 
(Karayianni et al., 2011). Light scattering intensity behavior is different for complexes 319 
formed at low and at high INS concentration. At low INS concentration I90 (and mass 320 
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of the complexes) increases, and then drops with ionic strength increase meaning that 321 
there is some additional aggregation of the complexes at low ionic strengths (but 322 
higher that the initially used ones for complex formation) and by increasing salt 323 
concentration the mass decreases again (Fig. 6(b)). In the case of complexes formed at 324 
higher INS concentration there are very small intensity changes (and mass changes) 325 
with added salt (Fig. S5(b)), which shows rather a small decrease in the mass of the 326 
complexes.  Rg/Rh values for these systems show a decrease and a plateau at I>0.1 M, 327 
reaching at an Rg/Rh value ca.0.9-1.0, which in turn may indicate more compact 328 
spherical structures than the initial ones. The observed behavior should be attributed 329 
to charge screening effects that weaken electrostatic interactions and promote 330 
hydrophobic effects. Due to the hydrophobic nature of the QNPHOSEO chains and 331 
their initial aggregation state, addition of salt may result in secondary aggregation or 332 
disruption of the complexes, depending on the initial conditions during complex 333 
formation.   334 
The hydrodynamic radius of the complexes, as a function of the added NaCl 335 
concentration, remained more or less unaffected in the case of complexes formed in 336 
PBS buffer (Fig. 6(a)). The same is true for the mass of the complexes as indicated by 337 
the I90 values (Fig. 6(b)). The morphology of the complexes showed some changes 338 
with more compact spherical structures being observed at higher salt concentrations, 339 
as indicated from the decrease in Rg/Rh values (Fig. 6(c)) (Karayianni et al., 2011). 340 
For these systems changes in the determined parameters are small and rather smooth. 341 
This may imply that the QNPHOSEO:INS complexes formed in PBS are more stable 342 
to ionic strength increase and may also have a structure closer to equilibrium.     343 
3.3. Protein structure within the complexes 344 
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The preservation of the enzymatic activity, which is directly correlated with the 345 
protein conformation, is an issue of major importance in most applications involving 346 
protein-polyelectrolyte complexes. For this reason, the structure of complexed protein 347 
was monitored via circular dichroism and infrared spectroscopic techniques, and 348 
representative results of QNPHOSEO:INS system at pH=7.40 and 0.154M NaCl are 349 
presented below. 350 
Firstly, circular dichroism (CD) was employed for the determination of the complexed 351 
protein structure. Fig. 7(a) presents the measured far-UV CD spectra of three 352 
representative solutions at CINS=0.07, 0.26 and 0.4 mg/ml of QNPHOSEO:INS 353 
system at pH=7.40 and 0.154M NaCl, and of neat INS at 1 mg/ml concentration and 354 
same solution conditions. As it can be seen, only small changes in the CD spectra 355 
between the neat and the complexed INS are observed. The analysis of the spectra 356 
carried out using the CDNN algorithm yielded similar results and the average 357 
percentages of protein secondary structure are summarized in Table S1. Obviously, 358 
the percentages of protein secondary structure are preserved for all solutions of the 359 
complexes, thus proving that the complexation does not cause structural disruption of 360 
the protein (Bouchard et al., 2000).  361 
Moreover, infrared (IR) spectroscopy measurements were performed and Fig. 7(b) 362 
shows the IR spectra of the same three representative solutions at CINS=0.07, 0.26 and 363 
0.4 mg/ml of QNPHOSEO:INS system at pH=7.40 and 0.154M NaCl in the Amide I 364 
and II region, including the corresponding spectrum of neat INS for comparison. The 365 
spectra have been normalized to the intensity of the Amide I band, after subtraction of 366 
the spectral contribution of the neat block polyelectrolyte copolymer. The constancy 367 
of the Amide I and II profiles, peaking at ca. 1658 and 1540 cm-1 respectively, 368 
indicates the absence of significant protein configuration changes, such as those 369 
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observed upon denaturation (Bouchard et al., 2000). Therefore, it can be concluded 370 
that insulin preserves its structure and activity after complexation. 371 
3.4. Encapsulation efficiency and in vitro release of INS 372 
Values of encapsulation efficiency varied from 10 to 40% for the different 373 
formulation as seen in Table S2. They were particularly affected by the dispersion 374 
medium and by the initial concentration of INS. Encapsulation efficiency increased 375 
with the increase of the initial concentration of the protein in the two aqueous 376 
dispersion media. The in vitro release of the INS from the nanocomplexes, at different 377 
molar ratios of the protein component, is presented in Fig. 8. It is observed that the in 378 
vitro release of the INS from the prepared polyelectrolyte aggregates is quite fast 379 
especially for the QNPHOSEO:INS nanoparticles of initial concentration of INS was 380 
0.067 mg/ml) (Fig. 8). Full insulin release was only observed with QNPHOSEO:INS 381 
nanoparticles (initial concentration of INS was 0.067 mg/ml during complex 382 
formation) after 50min (Fig. 8). Up to 80% of the insulin was released almost 383 
immediately from QNPHOSEO:INS nanoparticles (initial concentration of INS was 384 
0.027 mg/ml). Full insulin release was also observed with QNPHOSEO:INS 385 
nanoparticles (initial concentration of INS was 0.260 mg/ml) after 8 hours (Fig. 8). 386 
Biphasic drug release patterns were observed for this formulation. The release kinetics 387 
of INS from this nanosystem follow zero order kinetics, but separated in two phases 388 
with two distinct rates, an initial faster one followed by a slower one (Fig. 8). In our 389 
opinion, the determining factor of the release profile of the INS is the initial 390 
concentration of the protein, which affects the physicochemical and morphological 391 
characteristics of the complexes and consequently the release kinetics. From the 392 
application point of view, it can be concluded that encapsulation and release of insulin 393 
in the present nanosystems can be controlled via the ratio of the two components and 394 
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to a lesser extend by the physicochemical parameters of solution during initial 395 
complex formation. 396 
 397 
4. Conclusions  398 
We have studied the electrostatic complexation process between the block 399 
polyelectrolyte quaternized poly[3,5-bis(dimethylaminomethylene)hydroxystyrene]-400 
b-poly(ethylene oxide) (QNPHOSEO), which is a cationic-neutral polyelectrolyte, 401 
and INS. It was shown that the structure and solution behavior of the formed 402 
complexes depend on the ratio of the two components, as well as on the pH and the 403 
ionic strength of the solution during complex preparation. This study provides 404 
interesting and useful new insights into the interaction mechanism between oppositely 405 
charged block polyelectrolyte loose aggregates with stealth properties and proteins. 406 
The increase of the ionic strength in the solutions of the complexes induces charge 407 
screening and weakening of the electrostatic interactions that lead to different 408 
structures of the complexes. The size of complexes in biological medium (FBS) was 409 
not increased significantly. This observation indicates that QNPHOSEO copolymer 410 
imparts biological stability in the complexes. Moreover, the native protein structure is 411 
preserved upon complexation. Encapsulation efficiency increased with the increase of 412 
the initial concentration of the protein in PBS. The in vitro release of the INS from the 413 
prepared polyelectrolyte aggregates is quite slow especially for the QNPHOSEO:INS 414 
nanoparticles with the higher initial concentration of INS. The results of our study 415 
contribute to the overall scientific efforts to prepare efficient carriers for INS and 416 
could be useful in order to develop nanocarriers with increased efficacy, safety and 417 
tolerability. The prepared nanocarriers can disclose the pharmacokinetic reality of 418 
behavior of INS and improve its therapeutic value and side effects. This is because of 419 
the interdependence of particle size distribution and physicochemical characteristics, 420 
19 
 
coupled with the beneficial effects of different biomaterials on biological and 421 
pharmacokinetic processes. 422 
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Figure 1. a. Molecular structure of QNPHOSEO block polyelectrolyte (the degrees of 537 
polymerization are m=162 and n=334) b. Schematic representation of the formation 538 
of QNPHOSEO:INS complexes. 539 
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 542 
 543 
Figure 2. (a) Hydrodynamic radius, Rh,  and (b) light scattering intensity at 90°, I,   as 544 
a function of CINS, for the solutions of QNPHOSEO:INS system at pH=7.00 and 545 
0.01M NaCl (blue points) and at pH=7.40 and 0.154M NaCl (red points).  546 
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 548 
 549 
  550 
Figure 3. (a) ζ-potential and (b) Rg/Rh  as a function of CINS, for the solutions of 551 
QNPHOSEO:INS system at pH=7.00 and 0.01M NaCl (blue points) and at pH=7.40 552 
and 0.154M NaCl (red points).  553 
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  557 
 558 
 559 
Figure 4. (a) Hydrodynamic radius, Rh, and (b) ζ-potential as a function of CINS, for 560 
the solutions of QNPHOSEO:INS complexes as prepared at pH=7and 0.01M NaCl 561 
(blue points) and after dilution in FBS:PBS 10% (v/v) (red points).  562 
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  566 
Figure 5. (a) Hydrodynamic Radius, Rh, and (b) ζ-potential as a function of CINS, for 567 
the solutions of QNPHOSEO:INS complexes as prepared at pH=7.40 and 0.154M 568 
NaCl (blue points) and after dilution in FBS:PBS 10%(v/v) (red points).   569 
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  571 
  572 
Figure 6. (a) Hydrodynamic radius, Rh, (b) light scattering intensity at 90°, I, and (c) 573 
Rg/Rh, as a function of the added NaCl concentration of representative solutions, 574 
corresponding to low (CINS=0.027mg/ml –blue points and CINS=0.067mg/ml –red 575 
points) and high (CINS=0.260mg/ml –green points) CINS, of the QNPHOSEO:INS 576 
complexes prepared at pH=7.4 and I=0.154M.  577 
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Figure 7. a. Circular dichroism spectra in the far-UV and b. infrared spectra in the 583 
Amide I and II region of three representative solutions at CINS= 0.07, 0.26 and 0.4 584 
mg/ml of QNPHOSEO:INS system at pH=7.4 and 0.154M NaCl. The spectrum of 585 
neat INS at 1 mg/ml concentration and same solution conditions is included for 586 
comparison. 587 
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 589 
 590 
Figure 8. Cumulative INS release from three different QNPHOSEO based 591 
nanocarriers (whereas the initial concentration of protein was CINS=0.027 mg/ml –red 592 
line, CINS=0.067 mg/ml –blue line and CINS=0.260 mg/ml –green line) 37°C in PBS. 593 
Mean of three independent experiments run in triplicate, SD<10%. 594 
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Caption List 597 
Figure 1. a. Molecular structure of QNPHOSEO block polyelectrolyte (the degrees of 598 
polymerization are m=162 and n=334) b. Schematic representation of the formation 599 
of QNPHOSEO:INS complexes. 600 
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